Related Experiment Videos
Normocalcemic effect of gallium nitrate in a hypercalcemic rat model
J R Lin1, I Bekersky, N S Brown
1Department of Clinical Investigation, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Cancer Research
|January 15, 1995
Summary
Gallium nitrate effectively lowers high serum calcium levels in hypercalcemic rats when given intravenously or intraperitoneally. Oral administration proved ineffective due to poor bioavailability.
Area of Science:
- Pharmacology
- Endocrinology
- Nephrology
Background:
- Hypercalcemia is a condition characterized by elevated serum calcium levels.
- Current treatments for hypercalcemia include continuous intravenous infusion.
Purpose of the Study:
- To evaluate the efficacy of gallium nitrate in managing hypercalcemia.
- To compare different administration routes (intravenous, intraperitoneal, oral) of gallium nitrate.
Main Methods:
- Utilized an established rat model of hypercalcemia.
- Administered gallium nitrate daily at doses of 0.07-0.45 mmol/kg for 5 days via intravenous (i.v.), intraperitoneal (i.p.), or oral (p.o.) routes.
- Measured serum calcium levels and gallium bioavailability.
Main Results:
- Gallium nitrate demonstrated a dose-correlated normocalcemic response following i.v. and i.p. administration.
- Late administration of gallium nitrate was also effective in reducing serum calcium.
- Oral administration was ineffective, with only 15% bioavailability, explaining its lack of efficacy.
Conclusions:
- Daily i.v. bolus injections of gallium nitrate show potential as an effective treatment for hypercalcemia.
- Gallium nitrate's efficacy is route-dependent, with i.v. and i.p. routes being superior to oral administration.